Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 301–400 of 1,002
Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants
Aimanianda, V., Haensler, J., Lacroix‐Desmazes, S., Kaveri, S. V., & Bayry, J. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.005 · Cited by 148
Crystal Formation in Inflammation
Franklin, B. S., Mangan, M. S., & Latz, E. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055539 · Cited by 125
Toward precision adjuvants: optimizing science and safety
Nanishi, E., Dowling, D. J., & Levy, O. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000868 · Cited by 135
Immunology of TLR-independent vaccine adjuvants
Gregorio, E. D., D’Oro, U., & Wack, A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.003 · Cited by 127
Reimer, J. M., Karlsson, K. H., Lövgren-Bengtsson, K., Magnusson, S. E., Fuentes, A., & Stertman, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041451 · Cited by 123
Gonçalves, V. M., Matteucci, K. C., Buzzo, C. L., Miollo, B. H., Ferrante, D., Torrecilhas, A. C., Rodrigues, M. M., Alvarez, J. M., & Bortoluci, K. R. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002469 · Cited by 123
“Lysosomal cathepsins, ROS and/or potassium efflux have been reported to influence NLRP3 activation in response to diverse stimuli [35] [36] [37].”
BackgroundBorriello, F., Poli, V., Shrock, E. L., Spreafico, R., Liu, X., Pishesha, N., Carpenet, C., Chou, J. S., Gioia, M. D., McGrath, M. E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.009 · Cited by 125
Vaccine adjuvants: Tailoring innate recognition to send the right message
Lavelle, E. C., & McEntee, C. P. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.015 · Cited by 135
Prevention and Treatment of Papillomavirus-Related Cancers Through Immunization
Frazer, I. H., Leggatt, G. R., & Mattarollo, S. R. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101308 · Cited by 122
“Trials of HPV L1 protein as a therapeutic immunogen have also been conducted (144), given that animal studies have shown that L1 VLPs without adjuvant can invoke cell-mediated immune responses (145, 146), in contrast to alum-adjuvanted VLPs, which induce Th2-biased responses as a consequence of inflammasome activation…”
ResultDemento, S. L., Bonafé, N., Cui, W., Kaech, S. M., Caplan, M. J., Fikrig, E., Ledizet, M., & Fahmy, T. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000768 · Cited by 134
“This is in contrast to aluminum adjuvants (45, 46) or LPS-modified nanoparticles (15), which were shown to activate the NLRP3 inflammasome (Fig.”
Influenza vaccines: Past, present, and future
Kim, Y. H., Hong, K., Kim, H., & Nam, J. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2243 · Cited by 140
Chapter 6 Interleukin 5 in the Link Between the Innate and Acquired Immune Response
Takatsu, K., Kouro, T., & Nagai, Y. (2009) · Advances in immunology · doi:10.1016/s0065-2776(08)01006-7 · Cited by 139
Ellebedy, A. H., Lupfer, C., Ghoneim, H. E., DeBeauchamp, J., Kanneganti, T.-D., & Webby, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012455108 · Cited by 119
“It is interesting, however, that the murine antibody response to antigens emulsified in Freund’s complete adjuvant has been shown to be unaffected by the absence of ASC (7).”
BackgroundInfluentialTakeda, Y., Kataoka, K., Yamagishi, J., Ogawa, S., Seya, T., & Matsumoto, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.015 · Cited by 118
Adjuvant Activity of Cytokines
Tovey, M. G., & Lallemand, C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-585-9_19 · Cited by 129
“shown to induce the production of a varying array of cytokines including the type I interferons (IFNs), IFN-γ, interleukin-2, IL-12, and IL-18 (1, 2) that play an important role in the innate immune response and the establishment of adaptive immunity.”
BackgroundInfluentialRashidi, M., Simpson, D. S., Hempel, A., Frank, D. O., Petrie, E. J., Vince, A. J., Feltham, R., Murphy, J., Chatfield, S. M., Salvesen, G. S., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900228 · Cited by 130
“Similarly, despite reports implicating lysosomal rupture and cathepsin function in alum-induced NLRP3 inflammasome activation (12, 15), alum has been suggested to activate IL-1b in dendritic cells through plasma”
BackgroundResultTargeting NLRP3 Inflammasome Activation in Severe Asthma
Theofani, E., Semitekolou, M., Morianos, I., Samitas, Κ., & Xanthou, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101615 · Cited by 127
Moriwaki, K., Farias Luz, N., Balaji, S., De Rosa, M. J., O’Donnell, C. L., Gough, P. J., Bertin, J., Welsh, R. M., & Chan, F. K.-M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501662 · Cited by 116
“lease in a NLRP3 inflammasome-dependent manner (35).”
Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes
Powell, B. S., Andrianov, A. K., & Fusco, P. C. (2015) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2015.4.1.23 · Cited by 126
“tablished involvement of the NLRP3 inflam masome for adjuvant activity by aluminum salts [104,105], and that the role may not be not essential [83].”
BackgroundCa2+ released from calcium alginate gels can promote inflammatory responses in vitro and in vivo
Chan, G., & Mooney, D. J. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.08.002 · Cited by 115
“Inflammasome activation has been implicated in the success of adjuvants, such as alum [44,45], which suggests that Ca induction of IL-1b (and potentially inflammasome activation) may have interesting implications in the field of vaccination.”
BackgroundPhilbin, V. J., Dowling, D. J., Gallington, L. C., Cortés, G., Tan, Z. W., Suter, E. E., Chi, K. W., Shuckett, A., Stoler‐Barak, L., Tomai, M. A., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.042 · Cited by 125
Koenen, T. B., Stienstra, R., van Tits, L. J., Joosten, L. A. B., van Velzen, J. F., Hijmans, A., Pol, J. A., van der Vliet, J. A., Netea, M. G., Tack, C. J., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1480 · Cited by 115
B Cell Intrinsic MyD88 Signals Drive IFN-γ Production from T Cells and Control Switching to IgG2c
Barr, T. A., Brown, S., Mastroeni, P., & Gray, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803706 · Cited by 118
“KLH is also highly glycosylated and derived from an invertebrate, it may well be that the molecule itself activates a known or unknown pattern recognition pathway in a way analogous to the action of alum via the Nalp3 pathway (7, 8).”
BackgroundParticulate Adjuvant and Innate Immunity: Past Achievements, Present Findings, and Future Prospects
Kuroda, E., Coban, C., & Ishii, K. J. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.773326 · Cited by 125
“Differences in genetic background of the animal used, such International Reviews of Immunology as C57BL/6 [48, 54, 55] and mixed C57BL/6–129 [56], might contribute to the contrasting results.”
BackgroundMethodResultInfluentialThe Impact of Size on Particulate Vaccine Adjuvants
Shah, R. R., O’Hagan, D. T., Amiji, M. M., & Brito, L. A. (2014) · Nanomedicine · doi:10.2217/nnm.14.193 · Cited by 117
Developments in Vaccine Adjuvants
Firdaus, F. Z., Skwarczyński, M., & Tóth, I. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_8 · Cited by 122
Chen, Z., Liu, Y., Sun, B., Li, H., Dong, J., Zhang, L., Wang, L., Wang, P., Zhao, Y., & Chen, C. (2014) · Small · doi:10.1002/smll.201302825 · Cited by 115
Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?
Tomljenovic, L., & Shaw, C. A. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.08.008 · Cited by 132
The continued advance of vaccine adjuvants – ‘we can work it out’
O’Hagan, D. T., Lodaya, R. N., & Lofano, G. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101426 · Cited by 127
Mamo, T., & Poland, G. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.023 · Cited by 116
Rizwan, S. B., McBurney, W. T., Young, K., Hanley, T. L., Boyd, B. J., Rades, T., & Hook, S. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.020 · Cited by 112
“However, whether activation of the inflammasome is required for the adjuvant action of alum remains controversial and is currently an area of intense research [28].”
BackgroundEngineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice
Brandenberger, C., Rowley, N., Jackson‐Humbles, D. N., Zhang, Q., Bramble, L. A., Lewandowski, R. P., Wagner, J. G., Chen, W., Kaplan, B. L. F., Kaminski, N. E., et al. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-26 · Cited by 116
“The NLRP3 inflammasome is a protein complex required for splicing pro-IL1β into its active form [49], and was recently found to have an immuno-stimulatory function for aluminum adjuvants in vaccination [50].”
BackgroundDetermination of T Follicular Helper Cell Fate by Dendritic Cells
Krishnaswamy, J. K., Alsén, S., Yrlid, U., Eisenbarth, S. C., & Williams, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02169 · Cited by 123
“While the role of NLRs in priming Tfh cells has not been directly addressed, alum, a potent activator of the NLRP3 inflammasome (60, 61), has been used as an adjuvant in several studies (6, 62, 63).”
MethodSelf-citationClear and present danger? Engineered nanoparticles and the immune system
Fadeel, B. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13609 · Cited by 110
Dissolution of insulating oxide materials at the molecular scale
Ohlin, C. A., Villa, E. M., Rustad, J. R., & Casey, W. H. (2009) · Nature Materials · doi:10.1038/nmat2585 · Cited by 123
Activation of NLRP3 inflammasome by crystalline structures via cell surface contact
Hari, A., Zhang, Y., Tu, Z., Detampel, P., Stenner, M., Ganguly, A., & Shi, Y. (2014) · Scientific Reports · doi:10.1038/srep07281 · Cited by 111
“To test crystalinduced neutrophil infiltration, MSU was i.p. injected into the peritoneal cavities, the neutrophil infiltrates were gated on population double-positive for CD45/LY6G and counted by FACS.”
MethodOn vaccine's adjuvants and autoimmunity: Current evidence and future perspectives
Pellegrino, P., Clementi, E., & Radice, S. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.05.014 · Cited by 116
“Furthermore, antibody response induced by emulsions appears to have a more balanced IgG1:IgG2a profile compared with alum [60].”
BackgroundKorsholm, K. S., Petersen, R. V., Agger, E. M., & Andersen, P. L. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03164.x · Cited by 111
Burton, L., Paget, D., Binder, N. B., Bohnert, K., Nestor, B. J., Sculco, T. P., Santambrogio, L., Ross, F. P., Goldring, S. R., & Purdue, P. E. (2013) · Journal of Orthopaedic Research · doi:10.1002/jor.22190 · Cited by 110
“A number of mediators of inflammasome activation relevant to innate immunity have now been described, including adjuvants, silica particles, asbestos crystals, and urate, the causative agent in gout.(26,27,29,38) Two recent papers from Caicedo et al.”
BackgroundCombination adjuvants: the next generation of adjuvants?
Mutwiri, G., Gerdts, V., den Hurk, S. V. D. L., Auray, G., Eng, N. F., Garlapati, S., Babiuk, L. A., & Potter, A. A. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.154 · Cited by 123
Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
Chiang, C. L.-L., Kandalaft, L. E., & Coukos, G. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2011.572210 · Cited by 119
“Another phase I trial was conducted to investigate the safety, tolerability, and biological activity of a new CD40 agonistic IgG1 chimeric Chi Lob 7/4 mAb that was presented at the 2010 American Society of Clinical Oncolcogy (ASCO) Annual Meeting [197].”
BackgroundInfluentialAn Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology
Ratsimandresy, R. A., Dorfleutner, A., & Stehlik, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00440 · Cited by 109
“While some studies observed significantly attenuated airway inflammation, IgE production, and cytokine release in response to OVA in Nlrp3−/− mice (79, 216), others failed to observe any major contribution of NLRP3 (217, 218).”
BackgroundPlazyo, O., Romero, R., Unkel, R., Balancio, A., Mial, T. N., Xu, Y., Dong, Z., Hassan, S. S., & Gomez-Lopez, N. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.144139 · Cited by 109
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
Orr, M. T., Khandhar, A. P., Seydoux, E., Liang, H., Gage, E., Mikasa, T. J. T., Beebe, E. L., Rintala, N. D., Persson, K. H., Ahniyaz, A., et al. (2018) · npj Vaccines · doi:10.1038/s41541-018-0094-0 · Cited by 115
Aluminium adjuvants in vaccines – A way to modulate the immune response
Danielsson, R., & Eriksson, H. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.12.008 · Cited by 124
Philbin, V. J., & Levy, O. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819f195d · Cited by 118
Current adjuvants and new perspectives in vaccine formulation
Montomoli, E., Piccirella, S., Khadang, B., Mennitto, E., Camerini, R., & Rosa, A. D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.48 · Cited by 119
Malik, A. F., Hoque, R., Ouyang, X., Ghani, A., Hong, E., Khan, K., Moore, L. B., Ng, G., Munro, F., Flavell, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105152108 · Cited by 107
Self-citationBrereton, C. F., Sutton, C. E., Ross, P. J., Iwakura, Y., Pizza, M., Rappuoli, R., Lavelle, E. C., & Mills, K. H. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003789 · Cited by 113
A Role for the Inflammasome in Spontaneous Preterm Labor With Acute Histologic Chorioamnionitis
Gomez‐Lopez, N., Romero, R. J., Xu, Y., Plazyo, O., Unkel, R., Leng, Y., Than, N. G., Chaiworapongsa, T., Panaitescu, B., Dong, Z., et al. (2017) · Reproductive Sciences · doi:10.1177/1933719116687656 · Cited by 112
A Role for the Inflammasome in Spontaneous Labor at Term
Romero, R. J., Xu, Y., Plazyo, O., Chaemsaithong, P., Chaiworapongsa, T., Unkel, R., Than, N. G., Chiang, P. J., Dong, Z., Xu, Z., et al. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12440 · Cited by 113
Conforti‐Andreoni, C., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.81 · Cited by 123
A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity
Champion, C. I., Kickhoefer, V. A., Liu, G., Moniz, R. J., Freed, A. S., Bergmann, L. L., Vaccari, D., Raval-Fernandes, S., Chan, A. M., Rome, L. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005409 · Cited by 106
NLRP3 Inflammasome and Pathobiology in AMD
Celkova, L., Doyle, S., & Campbell, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010172 · Cited by 104
Distinct Licensing of IL-18 and IL-1β Secretion in Response to NLRP3 Inflammasome Activation
Schmidt, R. L., & Lenz, L. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045186 · Cited by 105
“However, unlike ATP, the L1S peptide failed to induce cell death.”
BackgroundInfluentialOxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome
Wynosky-Dolfi, M. A., Snyder, A. G., Philip, N. H., Doonan, P. J., Poffenberger, M. C., Avizonis, D., Zwack, E. E., Riblett, A. M., Hu, B., Strowig, T., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130627 · Cited by 103
Self-citationMadouri, F., Guillou, N., Fauconnier, L., Marchiol, T., Rouxel, N., Chenuet, P., Ledru, A., Apetoh, L., Ghiringhelli, F., Chamaillard, M., et al. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv012 · Cited by 104
Farrera, C., & Fadeel, B. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.007 · Cited by 92
Xie, Q., SHEN, W.-W., Zhong, J., Huang, C., Zhang, L., & Li, J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1755 · Cited by 113
“In addition, hyaluronan and β -amyloid plaque, the causative agents of Alzheimer's disease, elevate plasma glucose, as well as a diversity of environmental insults, including silica, have been found to induce NLRP3 inflammasome activation (26-32).”
Zhu, M., Du, L., Zhao, R., Wang, H. Y., Zhao, Y., Nie, G., & Wang, R. (2020) · ACS Nano · doi:10.1021/acsnano.0c00962 · Cited by 107
Health Effects of Asian Dust: A Systematic Review and Meta-Analysis
Hashizume, M., Kim, Y., Ng, C. F. S., Chung, Y., Madaniyazi, L., Bell, M. L., Guo, Y. L., Kan, H., Honda, Y., Yi, S., et al. (2020) · Environmental Health Perspectives · doi:10.1289/ehp5312 · Cited by 106
“The main constituents of Asian dust are silica and alumina (Ichinose et al. 2008b), and crystalline silica and aluminum have been suggested to cause cytokine-mediated in fl ammatory responses in the murine lung (Eisenbarth et al. 2008; Ichinose et al. 2008b).”
Monath, T. P. C., Lee, C. K., Julander, J. G., Brown, A., Beasley, D. W. C., Watts, D. M., Hayman, E. G., Guertin, P., Makowiecki, J., Crowell, J., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.023 · Cited by 115
Immune mechanisms of protection: can adjuvants rise to the challenge?
McKee, A. S., MacLeod, M. K. L., Kappler, J. W., & Marrack, P. (2010) · BMC Biology · doi:10.1186/1741-7007-8-37 · Cited by 120
NLRs, inflammasomes, and viral infection
Jacobs, S. R., & Damania, B. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312132 · Cited by 117
“controversial [55–59].”
Local innate immune responses in the vaccine adjuvant‐injected muscle
Liang, F., & Loré, K. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.19 · Cited by 115
Roger, S., Jelassi, B., Couillin, I., Pelegrín, P., Besson, P., & Jiang, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.029 · Cited by 110
NKT-cell help to B lymphocytes can occur independently of cognate interaction
Tonti, E., Galli, G., Malzone, C., Abrignani, S., Casorati, G., & Dellabona, P. (2008) · Blood · doi:10.1182/blood-2008-06-166249 · Cited by 108
Advances in Nod-like receptors (NLR) biology
Barbé, F., Douglas, T., & Saleh, M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.001 · Cited by 120
“aluminum hydroxide [142], cholesterol crystals [143] and uric acid crystals [136].”
BackgroundThe Role of Potassium in Inflammasome Activation by Bacteria
Arlehamn, C. S. L., Pétrilli, V., Gross, O., Tschopp, J., & Evans, T. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.067298 · Cited by 101
Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors
Zhivaki, D., Kennedy, S. N., Park, J., Borriello, F., Devant, P., Cao, A., Bahleda, K. M., Murphy, S. M., Aubin, C., Evavold, C. L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.026 · Cited by 109
Conjugate Vaccine Immunotherapy for Substance Use Disorder
Bremer, P. T., & Janda, K. D. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.013904 · Cited by 106
“3) (Eisenbarth et al., 2008; Kool et al., 2008a).”
Th17 cell based vaccines in mucosal immunity
Kumar, P., Chen, K., & Kolls, J. K. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.011 · Cited by 118
He, M., Ichinose, T., Kobayashi, M., Arashidani, K., Yoshida, S., Nishikawa, M., Takano, H., Sun, G., & Shibamoto, T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.02.017 · Cited by 101
What determines Th2 differentiation, in vitro and in vivo?
Paul, W. E. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.2 · Cited by 101
Chitin Particles Are Multifaceted Immune Adjuvants
Silva, C. A. D., Pochard, P., Lee, C. G., & Elias, J. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1877oc · Cited by 99
“Another is the impressive dependence of chitin on TLR-2 versus the reported LPS TLR-4–dependence of aluminum hydroxide (25) and the lesser role of TLR-2 in alum-driven responses.”
BackgroundInfluentialThe Effects of Maternal Exposure to Bisphenol A on Allergic Lung Inflammation into Adulthood
Bauer, S. M., Roy, A., Emo, J. A., Chapman, T. J., Georas, S. N., & Lawrence, B. P. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs227 · Cited by 108
“This leads to OVA uptake by spleen antigenpresenting cells and is believed to promote robust T H 2 immune responses in both inflammasome-dependent and -independent manners (Eisenbarth et al., 2008; Kool et al., 2008a).”
BackgroundBergmann‐Leitner, E. S., & Leitner, W. W. (2014) · Vaccines · doi:10.3390/vaccines2020252 · Cited by 117
The controversial relationship between NLRP3, alum, danger signals and the next‐generation adjuvants
Spreafico, R., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2010) · European Journal of Immunology · doi:10.1002/eji.200940039 · Cited by 98
A 3′UTR SNP in NLRP3 Gene is Associated With Susceptibility to HIV-1 Infection
Pontillo, A., Brandão, L. A. C., Guimarães, R. L., Segat, L., Athanasakis, E., & Crovella, S. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181dd17d4 · Cited by 100
The expression and function of Nod‐like receptors in neutrophils
Ekman, A., & Cardell, L. O. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03212.x · Cited by 97
Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations
Tomljenovic, L., & Shaw, C. (2012) · Lupus · doi:10.1177/0961203311430221 · Cited by 101
Analysis of NLRP3 in the Development of Allergic Airway Disease in Mice
Allen, I. C., Jania, C. M., Wilson, J. E., Tekeppe, E. M., Hua, X., Brickey, W. J., Kwan, M., Koller, B. H., Tilley, S. L., & Ting, J. P.-Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102488 · Cited by 96
“Nlrp3, Pycard, and Casp-1 mice were found to have significantly attenuated airway inflammation, Ig Ab production, and cytokine release in response to OVA (2, 9).”
BackgroundMethodInfluentialNew vaccines against influenza virus
Lee, Y., Kim, K., Ko, E.-J., Lee, Y., Kim, M., Kwon, Y., Tang, Y., Cho, M., Lee, Y., & Kang, S. (2014) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2014.3.1.12 · Cited by 120
Dhama, K., Saminathan, M., Jacob, S. S., Singh, M. K., Karthik, K., AMARPAL, A., Tiwari, R., Sunkara, L. T., Malik, Y. S., & Singh, R. K. (2015) · International Journal of Pharmacology · doi:10.3923/ijp.2015.253.290 · Cited by 116
The role of the NLRP3 Inflammasome in the pathogenesis of airway disease
Birrell, M. A., & Eltom, S. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.007 · Cited by 105
The vaccine adjuvant alum promotes IL‐10 production that suppresses Th1 responses
Oleszycka, E., McCluskey, S., Sharp, F. A., Muñoz‐Wolf, N., Hams, E., Gorman, A. L., Fallon, P. G., & Lavelle, E. C. (2018) · European Journal of Immunology · doi:10.1002/eji.201747150 · Cited by 109
Cerqueira, D. M., Gomes, M. T. R., Silva, A. L. N., Rungue, M., Assis, N. R. G., Guimarães, E. S., Morais, S. B., Brož, P., Zamboni, D. S., & Oliveira, S. C. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007519 · Cited by 104
Kim, E. H., Woodruff, M. C., Grigoryan, L., Maier, B. B., Lee, S. H., Mandal, P., Cortese, M., Natrajan, M. S., Ravindran, R., Ma, H., et al. (2020) · eLife · doi:10.7554/elife.52687 · Cited by 103
“Furthermore, alum is known to rapidly activate NALP3 inflammasome (Eisenbarth et al., 2008; Li et al., 2007; McKee et al., 2009), although opinions vary about the relative importance of this in mediating its immunogenicity (De Gregorio et al.”
BackgroundExploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
Ong, G. H., Lian, B. S. X., Kawasaki, T., & Kawai, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.745016 · Cited by 102
Comparison of adjuvant and adjuvant‐free murine experimental asthma models
Conrad, M. L., Yildirim, A. Ö., Sonar, S. S., Kılıç, A., Sudowe, S., Lunow, M., Teich, R., Renz, H. E., & Garn, H. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03260.x · Cited by 113
Shi, W., Feng, W., Li, S., Cui, Y., Liu, S., Jiang, H., Liu, Y., & Zhang, H. (2023) · ACS Nano · doi:10.1021/acsnano.3c00901 · Cited by 96
Pavot, V., Rochereau, N., Primard, C., Genin, C., Pérouzel, É., Lioux, T., Paul, S., & Verrier, B. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.015 · Cited by 107
Vaccine adjuvants: A priority for vaccine research
Harandi, A. M., Medaglini, D., & Shattock, R. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.12.084 · Cited by 94
Chemical probing reveals insights into the signaling mechanism of inflammasome activation
Gong, Y., Wang, X., Wang, J., Yang, Z., Li, S., Yang, J., Liu, L., Lei, X., & Shao, F. (2010) · Cell Research · doi:10.1038/cr.2010.135 · Cited by 105
Hirota, J. A., Gold, M. J., Hiebert, P., Parkinson, L. G., Wee, T., Smith, D. E., Hansbro, P. M., Carlsten, C., vanEeden, S. F., Sin, D. D., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0158oc · Cited by 101
The role of NOD-like Receptors in shaping adaptive immunity
Williams, A., Flavell, R. A., & Eisenbarth, S. C. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.004 · Cited by 92
Self-citationFrancica, J. R., Zak, D. E., Linde, C., Siena, E., Johnson, C., Juraska, M., Yates, N. L., Gunn, B., De Gregorio, E., Flynn, B. J., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017011411 · Cited by 93
Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes
Lin, L., Tan, B., Pantapalangkoor, P., Ho, T., Hujer, A. M., Taracila, M. A., Bonomo, R. A., & Spellberg, B. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.008 · Cited by 92
Use of Protamine in Nanopharmaceuticals—A Review
Ruseska, I., Fresacher, K., Petschacher, C., & Zimmer, A. (2021) · Nanomaterials · doi:10.3390/nano11061508 · Cited by 98
Regulation of adaptive immunity by the NLRP3 inflammasome
Chen, M., Wang, H., Chen, W., & Meng, G. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.025 · Cited by 100
“In addition, neither complete Freund's adjuvant (CFA) nor incomplete Freund's adjuvant (IFA) induced IL-1β production by macrophages [46,25].”
Influential
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.